TIRmed Pharma
Developing new treatments for eczema and virus
- CEO: Anna-Lena Spetz
- First investment year: 2020
- Fund: Stockholm
- Business sector: Life Science
TIRmed Pharma develops drug candidates addressing major clinical needs. One is a cream for the treatment of eczema and the other a nasal spray for viral respiratory infections, such as influenza, RS virus and Corona.